|
Top Statistics
|
| Market Cap |
2 M |
Forward PE |
0.0000 |
Revenue Growth |
270.50 % |
| Current Ratio |
1.41 |
Trailing PE |
0.0000 |
Earnings Growth |
0.00 % |
| Profit Margins |
0.00 % |
Peg Ratio |
|
Dividend Yield |
0.00 % |
| Enterprice / EBITA |
0.4600 |
Enterprise / Revenue |
-1.37 |
Price To Sales Trailing12 Months |
0.9670 |
|
Profitability
|
| Profit Margins |
0.00 % |
Operating Margins |
-493.25 % |
|
|
Balance Sheet
|
| Total Cash |
6 M |
Total Cash Per Share |
4.63 |
Total Debt |
374417 |
| Total Debt To Equity |
8.19 |
Current Ratio |
1.41 |
Book Value Per Share |
3.52 |
|
|
All Measures
|
| Short Ratio |
11.00 % |
Message Board Id |
finmb_1757573328 |
Shares Short Prior Month |
114761 |
| Return On Equity |
-2.43 |
City |
New Romney |
Uuid |
5fccdbf8-128a-362f-956c-630b56de404b |
| Previous Close |
1.62 |
First Trade Date Epoch Utc |
1 B |
Book Value |
3.52 |
| Beta |
1.52 |
Total Debt |
374417 |
Volume |
346543 |
| Price To Book |
0.4825 |
Last Split Date |
1 B |
Fifty Two Week Low |
1.22 |
| Total Cash Per Share |
4.63 |
Total Revenue |
2 M |
Shares Short Previous Month Date |
1 B |
| Max Age |
86400 |
Sand P52 Week Change |
0.3133 |
Operating Margins |
-493.25 % |
| Net Income To Common |
-31840168 |
Short Percent Of Float |
0.0609 |
Implied Shares Outstanding |
1 M |
| Trailing Peg Ratio |
None |
Last Fiscal Year End |
1 B |
Average Daily Volume10 Day |
182190 |
| Average Volume10days |
182190 |
Total Cash |
6 M |
Next Fiscal Year End |
1 B |
| Revenue Per Share |
9.39 |
Held Percent Insiders |
0.0165 |
Ebitda Margins |
-297.43 % |
| Trailing PE |
0.0000 |
Date Short Interest |
1 B |
Most Recent Quarter |
1 B |
| Regular Market Previous Close |
1.62 |
Target Low Price |
0.0000 |
Gmt Off Set Milliseconds |
-18000000 |
| Fifty Day Average |
1.84 |
Open |
1.62 |
Free Cashflow |
-8990619 |
| Dividend Yield |
0.00 % |
Return On Assets |
-0.2551 |
Time Zone Short Name |
EST |
| Trailing Eps |
-524.76 |
Day Low |
1.62 |
Address1 |
1a, 1b Learoyd Road |
| Shares Outstanding |
1 M |
Price Hint |
4 |
Target High Price |
0.0000 |
| Website |
https://www.akandacorp.com |
52 Week Change |
-0.9566 |
Average Volume |
368382 |
| Recommendation Key |
none |
Forward Eps |
0.0000 |
Compensation As Of Epoch Date |
1 B |
| Quick Ratio |
117.20 % |
Last Split Factor |
1:2 |
Regular Market Day High |
1.98 |
| Is_sp_500 |
False |
Profit Margins |
0.00 % |
Debt To Equity |
8.19 |
| Fifty Two Week High |
56.80 |
Day High |
1.98 |
Shares Short |
86900 |
| Regular Market Open |
1.62 |
Industry Key |
drug-manufacturers-specialty-generic |
Earnings Growth |
0.00 % |
| Enterprise To Revenue |
-1.37 |
Revenue Growth |
270.50 % |
Shares Percent Shares Out |
0.0609 |
| Operating Cashflow |
-3181070 |
Currency |
USD |
Time Zone Full Name |
America/New_York |
| Market Cap |
2 M |
Is_nasdaq_100 |
False |
Zip |
TN28 8XU |
| Quote Type |
EQUITY |
Industry |
Drug Manufacturers - Specialty & Generic |
Long Name |
Akanda Corp. |
| Regular Market Day Low |
1.62 |
Current Price |
1.70 |
Enterprise To Ebitda |
0.4600 |
| Financial Currency |
USD |
Current Ratio |
1.41 |
Gross Margins |
10.35 % |
| Industry Disp |
Drug Manufacturers - Specialty & Generic |
Country |
United Kingdom |
Float Shares |
1 M |
| Two Hundred Day Average |
6.36 |
Enterprise Value |
-3433362 |
Price To Sales Trailing12 Months |
0.9670 |
| Forward PE |
0.0000 |
Regular Market Volume |
346543 |
Ebitda |
-7460471 |
| Exchange |
NCM |
|
|